fda glp-1 warning letters september 2025 news issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of The FDA Just Sent 25

It also encourages feelings of fullness, which can help reduce cravings and support consistent, long-term wellness as part of a balanced lifestyle

Brand Name: Retatrutide Pen Strength: Triple Agonist for GLP-1, GIP, and Glucagon Receptors Manufacturer: Regenmed Price: On Request Retatrutide must always be used under the supervision of a Registered Medical Practitioner (RMP)

This review summarises recent advances in the understanding of diabetic gastroparesis, with an emphasis on the current therapies that influence GE, and the bidirectional relationship between glycaemic control and GE.

Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.

Berberine is an isoquinoline alkaloid found in the roots and rhizomes of various medicinal plants, with an extensive history for managing type 2 diabetes [5]